UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.752

Sortiert nach

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Lancet neurology, 2014-02, Vol.13 (2), p.141-149

2014

Volltextzugriff (PDF)

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Clinical pharmacokinetics, 2023-04, Vol.62 (4), p.609-621

2023

Volltextzugriff (PDF)

Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist

Journal of clinical pharmacology, 2023-09, Vol.63 (9), p.1017-1025

2023

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers

Clinical and translational science, 2023-03, Vol.16 (3), p.536-547

2023

Volltextzugriff (PDF)

Multi-ahead electrical conductivity forecasting of surface water based on machine learning algorithms

Applied water science, 2023-10, Vol.13 (10), p.192-20, Article 192

2023

Volltextzugriff (PDF)

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

The AAPS journal, 2013-04, Vol.15 (2), p.316-323

2013

Volltextzugriff (PDF)

Evaluation of the potential drug interactions mediated through P‐gp, OCT2, and MATE1/2K with filgotinib in healthy subjects

Clinical and translational science, 2022-02, Vol.15 (2), p.361-370

2022

Volltextzugriff (PDF)

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants

Clinical pharmacology in drug development, 2022-02, Vol.11 (2), p.235-245

2022

Volltextzugriff (PDF)

Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e005267

2023

Volltextzugriff (PDF)

Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers

Clinical and translational science, 2022-06, Vol.15 (6), p.1492-1499

2022

Volltextzugriff (PDF)

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

The Lancet (British edition), 2019-06, Vol.393 (10188), p.2303-2311

2019

Volltextzugriff (PDF)

Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors

Journal for immunotherapy of cancer, 2024-04, Vol.12 (4), p.e008547

2024

Volltextzugriff (PDF)

Integration of GIS and Remote Sensing with RUSLE Model for Estimation of Soil Erosion

Land (Basel), 2023-01, Vol.12 (1), p.116

2023

Volltextzugriff (PDF)

Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I Trials

Clinical and translational science, 2019-09, Vol.12 (5), p.470-480

2019

Volltextzugriff (PDF)

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2019-11, Vol.71 (11), p.1788-1800

2019

Volltextzugriff (PDF)

Azithromycin To Prevent Bronchopulmonary Dysplasia in Ureaplasma-Infected Preterm Infants: Pharmacokinetics, Safety, Microbial Response, and Clinical Outcomes with a 20-Milligram-per-Kilogram Single Intravenous Dose

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2127-2133

2013

Volltextzugriff (PDF)

Long-Term Shoreline and Islands Change Detection with Digital Shoreline Analysis Using RS Data and GIS

Water (Basel), 2023-01, Vol.15 (2), p.244

2023

Volltextzugriff (PDF)

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2020-06, Vol.158 (8), p.2139-2149.e14

2020

Volltextzugriff (PDF)

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet (British edition), 2018-06, Vol.391 (10139), p.2503-2512

2018

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients

Clinical pharmacokinetics, 2020-03, Vol.59 (3), p.311-326

2020

Volltextzugriff (PDF)

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

Journal of allergy and clinical immunology, 2020-03, Vol.145 (3), p.877-884

2020

Volltextzugriff (PDF)

Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus

Clinical pharmacokinetics, 2020-03, Vol.59 (3), p.335-347

2020

Volltextzugriff (PDF)

Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies

Journal of clinical pharmacology, 2024-06, Vol.64 (6), p.713-718

2024

Volltextzugriff (PDF)

Unraveling the Impact of Cumin-Centric Cropping Sequences on Cumin Yield, Economic Viability, and Dynamics of Soil Enzymatic Activities in Hot Arid Climatic Conditions

Agronomy (Basel), 2023-12, Vol.13 (12), p.3023

2023

Volltextzugriff (PDF)

Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials

Clinical pharmacokinetics, 2019-03, Vol.58 (3), p.375-387

2019

Volltextzugriff (PDF)

1 – 25 von 2.752

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.175)
Mit Volltextzugriff
(2.492)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.642)
Life Sciences & Biomedicine
(1.042)
Humans
(419)
Technology
(411)
Physical Sciences
(362)
Male
(291)
Engineering
(256)
Female
(255)
Middle Aged
(177)
Animals
(171)
Adult
(168)
Chemistry
(167)
Pharmacology & Pharmacy
(163)
Science & Technology - Other Topics
(127)
Medicine
(122)
Patients
(122)
Aged
(115)
Computer Science
(107)
Medicine & Public Health
(107)
Engineering, Electrical & Electronic
(106)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist

Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers

Multi-ahead electrical conductivity forecasting of surface water based on machine learning algorithms

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Evaluation of the potential drug interactions mediated through P‐gp, OCT2, and MATE1/2K with filgotinib in healthy subjects

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants

Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors

Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors

Integration of GIS and Remote Sensing with RUSLE Model for Estimation of Soil Erosion

Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I Trials

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double‐Blind, Randomized Controlled Trial

Azithromycin To Prevent Bronchopulmonary Dysplasia in Ureaplasma-Infected Preterm Infants: Pharmacokinetics, Safety, Microbial Response, and Clinical Outcomes with a 20-Milligram-per-Kilogram Single Intravenous Dose

Long-Term Shoreline and Islands Change Detection with Digital Shoreline Analysis Using RS Data and GIS

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus

Feasibility of Using Population Pharmacokinetics‐Based Virtual Control Groups in Organ Impairment Studies

Unraveling the Impact of Cumin-Centric Cropping Sequences on Cumin Yield, Economic Viability, and Dynamics of Soil Enzymatic Activities in Hot Arid Climatic Conditions

Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials

Suchergebnisse filtern